Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 17856-0921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 17856-0921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17856 0921 01

17856 0921 01
This is a package of Sevelamer Carbonate consisting of 100 tablets with a quantity identifier of 17856-0921-01. It includes an insert detailing dosage guidelines and indications with storage guidelines to be kept at a controlled room temperature of 20-25°C. The product should be kept out of reach of children. The information includes a GTIN of 0017856002117 with SIN 36690102 and an expiry date of 08126121 for Lot 380001. The manufacturer is Atlantic Biologicals Corporation with the address at Moricvil, NC 27560 Miami FI 33170. There's also a reorder number 800.509.7592.*
FDA Label Image

Image Description (Sevelamer Fig1)

Image Description (Sevelamer Fig1)
This is a graph (Figure 3) that shows the percentage of patients who achieved a reduction in serum phosphorus levels (mg/dL) at least as much as the value on the X-axis, with the maximum percentage being 100%. The graph includes data on the effect of Sevelamer Hydrochloride on serum phosphorus levels compared to baseline, with a distinction between worsened or improved levels, and an indication of whether there was an increase or reduction in serum phosphorus levels.*
FDA Label Image

Image Description (Sevelamer Fig2)

FDA Label Image

Chemical Structure (Sevelamer Str)

Chemical Structure (Sevelamer Str)
This text describes the chemical structure of Sevelamer Carbonate, a medication used to treat high levels of phosphate in the blood of people with chronic kidney disease. It includes a schematic representation of the compound, its molecular formula, and the number of specific groups present in its structure.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.